Insulin-like growth factor-1 and epidermal growth factor (EGF) downregulation and fibroblast growth factor-2 (FGF2) up-regulation seem to constitute key features of endometrial cancer progression, as demonstrated in a collection of 30 cancer specimens that were compared to normal adjacent tissue. This evidence concerns the gene IGF1 and endometrial cancer.